• ქართული
  • English
  • France's Sanofi to buy biotech firm Synthorx for $2.5 billion

    Sanofi said on Monday it had agreed to buy California-headquartered biotechnology firm Synthorx in a cash deal worth about $2.5 billion aimed at beefing up the French drugmaker’s pipeline of drugs for cancer and auto-immune disorders.

    Market Quotes by TradingView